Concepedia

Hermann Dietzfelbinger

HD

Statistics

Publications

14

Citations

1.5K

H-Index

12

Active since

1977

Affiliations

Technical University of Munich(Current)

Ludwig-Maximilians-Universität München

LMU Klinikum

Klinikum St. Marien Amberg

Marienhospital Stuttgart

Hermann Dietzfelbinger is an author at Technical University of Munich specializing in medicine, oncology, and hematologic oncology.

Publications per year

1977–2020

14

Publications

14

Extramedullary plasmacytoma

Christoph Alexiou, Reinhardt J. Kau, Hermann Dietzfelbinger et al. · Cancer · 1999 · 567 citations · Full text

, , +6

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Michael Hallek, Irmgard Langenmayer, Christoph Nerl et al. · PubMed · 1999 · 236 citations

, , +9

Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

S. Danhauser-Riedl, E. Hausmann, Hans-D. Schick et al. · Investigational New Drugs · 1993 · 152 citations

, , +10

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

T. Schilling, K. B. Keppler, Manfred Heim et al. · Investigational New Drugs · 1995 · 149 citations

, , +5

An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine

U. Jehn, R. Bartl, Hermann Dietzfelbinger et al. · Leukemia · 2004 · 117 citations

, , +7

1–5 of 14